These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 19756487)

  • 21. Suppressor of cytokine signalling-3 expression inhibits cytokine-mediated destruction of primary mouse and rat pancreatic islets and delays allograft rejection.
    Rønn SG; Börjesson A; Bruun C; Heding PE; Frobøse H; Mandrup-Poulsen T; Karlsen AE; Rasschaert J; Sandler S; Billestrup N
    Diabetologia; 2008 Oct; 51(10):1873-82. PubMed ID: 18648765
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival of an islet allograft deficient in iNOS after implantation into diabetic NOD mice.
    Börjesson A; Andersson AK; Sandler S
    Cell Transplant; 2006; 15(8-9):769-75. PubMed ID: 17269447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin-1 plus gamma-interferon-induced pancreatic beta-cell dysfunction is mediated by beta-cell nitric oxide production.
    Thomas HE; Darwiche R; Corbett JA; Kay TW
    Diabetes; 2002 Feb; 51(2):311-6. PubMed ID: 11812737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Otubain 2 is a novel promoter of beta cell survival as revealed by siRNA high-throughput screens of human pancreatic islets.
    Beck A; Vinik Y; Shatz-Azoulay H; Isaac R; Streim S; Jona G; Boura-Halfon S; Zick Y
    Diabetologia; 2013 Jun; 56(6):1317-26. PubMed ID: 23515685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Strain-dependent difference in inducible nitric oxide synthesis (iNOS) expression in rat pancreatic islets correlates with interferon regulating factor 1 (IRF-1) and heat shock protein 70 (HSP70) expression.
    Johannesen J; Pociot F; Karlsen AE; Mandrup-Poulsen T; Nerup J
    Eur Cytokine Netw; 2001; 12(3):501-9. PubMed ID: 11566631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exercise increases pancreatic β-cell viability in a model of type 1 diabetes through IL-6 signaling.
    Paula FM; Leite NC; Vanzela EC; Kurauti MA; Freitas-Dias R; Carneiro EM; Boschero AC; Zoppi CC
    FASEB J; 2015 May; 29(5):1805-16. PubMed ID: 25609426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-17A increases the expression of proinflammatory chemokines in human pancreatic islets.
    Grieco FA; Moore F; Vigneron F; Santin I; Villate O; Marselli L; Rondas D; Korf H; Overbergh L; Dotta F; Marchetti P; Mathieu C; Eizirik DL
    Diabetologia; 2014 Mar; 57(3):502-11. PubMed ID: 24352375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of the prostaglandin D
    Abadpour S; Tyrberg B; Schive SW; Huldt CW; Gennemark P; Ryberg E; Rydén-Bergsten T; Smith DM; Korsgren O; Skrtic S; Scholz H; Winzell MS
    Diabetologia; 2020 Jul; 63(7):1355-1367. PubMed ID: 32350565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interleukin-4 or interleukin-10 expressed from adenovirus-transduced syngeneic islet grafts fails to prevent beta cell destruction in diabetic NOD mice.
    Smith DK; Korbutt GS; Suarez-Pinzon WL; Kao D; Rajotte RV; Elliott JF
    Transplantation; 1997 Oct; 64(7):1040-9. PubMed ID: 9381527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IRF-1 inhibits NF-κB activity, suppresses TRAF2 and cIAP1 and induces breast cancer cell specific growth inhibition.
    Armstrong MJ; Stang MT; Liu Y; Yan J; Pizzoferrato E; Yim JH
    Cancer Biol Ther; 2015; 16(7):1029-41. PubMed ID: 26011589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Production and function of IL-12 in islets and beta cells.
    Taylor-Fishwick DA; Weaver JR; Grzesik W; Chakrabarti S; Green-Mitchell S; Imai Y; Kuhn N; Nadler JL
    Diabetologia; 2013 Jan; 56(1):126-35. PubMed ID: 23052055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microassay for glucose-induced preproinsulin mRNA expression to assess islet functional potency for islet transplantation.
    Omori K; Mitsuhashi M; Todorov I; Rawson J; Shiang KD; Kandeel F; Mullen Y
    Transplantation; 2010 Jan; 89(2):146-54. PubMed ID: 20098276
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytokine-induced inhibition of insulin release from mouse pancreatic beta-cells deficient in inducible nitric oxide synthase.
    Andersson AK; Flodström M; Sandler S
    Biochem Biophys Res Commun; 2001 Feb; 281(2):396-403. PubMed ID: 11181061
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sulforaphane inhibits the interferon-γ-induced expression of MIG, IP-10 and I-TAC in INS‑1 pancreatic β-cells through the downregulation of IRF-1, STAT-1 and PKB.
    Park YK; Ramalingam M; Kim S; Jang BC; Park JW
    Int J Mol Med; 2017 Sep; 40(3):907-912. PubMed ID: 28677733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin-like growth factors prevent cytokine-mediated cell death in isolated islets of Langerhans from pre-diabetic non-obese diabetic mice.
    Hill DJ; Petrik J; Arany E; McDonald TJ; Delovitch TL
    J Endocrinol; 1999 Apr; 161(1):153-65. PubMed ID: 10194539
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of interferon regulatory factor-1 in double-stranded RNA-induced iNOS expression by mouse islets.
    Blair LA; Maggi LB; Scarim AL; Corbett JA
    J Biol Chem; 2002 Jan; 277(1):359-65. PubMed ID: 11694524
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interferon-gamma increases the sensitivity of islets of Langerhans for inducible nitric-oxide synthase expression induced by interleukin 1.
    Heitmeier MR; Scarim AL; Corbett JA
    J Biol Chem; 1997 May; 272(21):13697-704. PubMed ID: 9153221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of primary non-function of islet xenografts in autoimmune diabetic NOD mice by anti-inflammatory agents.
    Gysemans C; Stoffels K; Giulietti A; Overbergh L; Waer M; Lannoo M; Feige U; Mathieu C
    Diabetologia; 2003 Aug; 46(8):1115-23. PubMed ID: 12879250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Osteopontin protects the islets and beta-cells from interleukin-1 beta-mediated cytotoxicity through negative feedback regulation of nitric oxide.
    Arafat HA; Katakam AK; Chipitsyna G; Gong Q; Vancha AR; Gabbeta J; Dafoe DC
    Endocrinology; 2007 Feb; 148(2):575-84. PubMed ID: 17110428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human pancreatic islets transfected to produce an inhibitor of TNF are protected against destruction by human leukocytes.
    Dobson T; Fraga D; Saba C; Bryer-Ash M; Gaber AO; Gerling IC
    Cell Transplant; 2000; 9(6):857-65. PubMed ID: 11202571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.